Infusion Brands International, Inc.

Infusion Brands International, Inc.

INBI
Infusion Brands International, Inc.US flagOther OTC
0.00
USD
- -
- -
18,146.00Market Cap
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2010 Y
2011 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.07
0.67
0.19
0.05
0.1
0.08
Basic EPS, GAAP
-0.04
- -
-0.01
-2.64
-4.89
-0.39
-0.71
-0.1
-0.1
-0.16
Free Cash Flow per Basic Share
- -
- -
-0.01
-0.17
-0.08
-0.62
-0.04
-0.04
-0.04
-0.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.04
-0.04
-0.04
-2.28
-4.74
-3.21
-0.38
-0.37
-0.37
-0.39
Tangible Book Value per Share
- -
-0.01
- -
-2.19
-2.55
-2.83
-0.04
-0.06
-0.14
-0.27
Basic Weighted Avg Shares
5
5
6
11
14
15
138
159
178
181
Sales/Revenue/Turnover
- -
- -
- -
- -
1
10
26
8
18
14
Operating Margin (%)
- -
- -
- -
-148,119.73
-448.11
-39.14
-32.85
-155.84
-37.81
-38.84
Depreciation Expense
- -
- -
- -
1
1
1
2
1
- -
- -
Net Income, GAAP
- -
- -
- -
-24
-15
-3
-31
-16
-7
-6
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
-920,484.96
-1,591.74
-26.83
-118.95
-192.81
-38.19
-40.76
Working Capital
- -
- -
- -
- -
-2
- -
5
2
1
-4
LT Debt
- -
- -
- -
- -
- -
2
2
2
2
2
Total Equity
- -
- -
- -
-22
-35
-40
-3
-7
-18
-41
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
30.87
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'12
Jun'12
Sep'12
ST Debt
- -
- -
2
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
7
7
7
Shares Outstanding
181
181
181
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Mar'12
Jun'12
Sep'12
Total Current Assets
4
4
6
Cash, Cash Equivalents & STI
1
- -
- -
Accounts Receivable, Net
1
1
1
Inventories
2
2
2
Total Current Liabilities
5
6
9
Payables & Accruals
5
5
6
ST Debt
- -
- -
2
Deferred Revenue
- -
1
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
62.29%
171.2%
Free Cash Flow
- -
137.5%
9.16%
Net Income, GAAP
- -
169.83%
-56.79%
Sales/Revenue/Turnover
- -
7,536.59%
118.18%
Total Cash Common Dividend
- -
- -
-83.72%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
2
1
5
4
8
2011
4
5
2
6
18
2012
2
3
3
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
-0.06
- -
0.09
- -
-0.1
2011
-0.02
-0.02
-0.03
- -
-0.1
2012
-0.04
-0.04
-0.05
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Shadron Lee Stastney
Full Time Employees
47
Sector
Consumer Defensive
Industry
Household & Personal Products
Address
14375 Myerlake Circle Clearwater FL United States of America 33760
IPO Date
Feb 12, 2013
Business
Infusion Brands International, Inc. (INBI) operates as a holding company focused on acquiring, developing, and scaling consumer brands in the health, wellness, and lifestyle sectors. The company offers a portfolio of branded products including nutritional supplements, functional beverages, personal care items, and wellness accessories, distributed through e-commerce platforms, retail partners, and direct-to-consumer channels. Its core services encompass brand management, product formulation, supply chain optimization, and digital marketing strategies tailored for growth-stage consumer goods companies. Headquartered in Miami, Florida, and founded in 2021, Infusion Brands International serves target markets in North America and Europe, with expanding operations into Asia-Pacific regions. The company targets health-conscious consumers, retailers, and distributors seeking innovative, science-backed wellness solutions across its business segments of nutraceuticals, beauty, and functional foods. In the last two years, Infusion Brands International completed a significant funding round in early 2025, raising $25 million in Series B financing led by strategic investors to fuel acquisitions and product launches. It recently acquired WellnessForge Brands in Q3 2025, integrating premium adaptogen-based supplements into its portfolio, and announced a strategic partnership with a leading e-commerce platform to enhance global distribution. These moves mark a major expansion phase, including the launch of a new line of AI-personalized nutrition products and a reorganization to streamline international operations.